DZ452A1 - Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain. - Google Patents

Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain.

Info

Publication number
DZ452A1
DZ452A1 DZ826637A DZ826637A DZ452A1 DZ 452 A1 DZ452 A1 DZ 452A1 DZ 826637 A DZ826637 A DZ 826637A DZ 826637 A DZ826637 A DZ 826637A DZ 452 A1 DZ452 A1 DZ 452A1
Authority
DZ
Algeria
Prior art keywords
human
paptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Application number
DZ826637A
Other languages
English (en)
French (fr)
Inventor
Ronald Eugene Chance
Bruce Hill Frank
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ452A1 publication Critical patent/DZ452A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DZ826637A 1981-08-27 1982-08-24 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain. DZ452A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
DZ452A1 true DZ452A1 (fr) 2004-09-13

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ826637A DZ452A1 (fr) 1981-08-27 1982-08-24 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain.

Country Status (20)

Country Link
JP (1) JPS5846024A (xx)
AU (1) AU551879B2 (xx)
BE (1) BE894185A (xx)
CA (1) CA1176158A (xx)
CH (1) CH650679A5 (xx)
DE (1) DE3232034A1 (xx)
DZ (1) DZ452A1 (xx)
FR (1) FR2513126B1 (xx)
GB (1) GB2104382B (xx)
IE (1) IE54119B1 (xx)
IL (1) IL66611A0 (xx)
IT (1) IT1153182B (xx)
LU (1) LU84359A1 (xx)
MW (1) MW3882A1 (xx)
NL (1) NL192192C (xx)
NZ (1) NZ201682A (xx)
PH (1) PH19361A (xx)
SE (1) SE460334B (xx)
ZA (1) ZA826159B (xx)
ZW (1) ZW17482A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ　インダストリ　アクティーゼルスカブ ポリペプチド製剤
JP2606915B2 (ja) * 1987-02-25 1997-05-07 ノボ ノルディスク アクティーゼルスカブ 新規インシュリン誘導体
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
ATE63821T1 (de) * 1987-08-14 1991-06-15 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
EP1817049B1 (en) * 2004-11-22 2012-08-01 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (ko) 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
EP2780030A4 (en) 2011-11-17 2015-11-18 Cebix Ab PEGYLATED C-PEPTIDE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
AU8759482A (en) 1983-03-03
IE822064L (en) 1983-02-27
ZA826159B (en) 1984-04-25
SE8204873D0 (sv) 1982-08-25
NL192192B (nl) 1996-11-01
BE894185A (fr) 1983-02-24
AU551879B2 (en) 1986-05-15
LU84359A1 (fr) 1983-02-28
PH19361A (en) 1986-04-02
CA1176158A (en) 1984-10-16
GB2104382A (en) 1983-03-09
DE3232034C2 (xx) 1991-04-11
JPS5846024A (ja) 1983-03-17
SE460334B (sv) 1989-10-02
SE8204873L (sv) 1983-02-28
IE54119B1 (en) 1989-06-21
CH650679A5 (de) 1985-08-15
FR2513126A1 (fr) 1983-03-25
IT8223017A0 (it) 1982-08-27
GB2104382B (en) 1984-12-19
ZW17482A1 (en) 1982-11-17
IT1153182B (it) 1987-01-14
MW3882A1 (en) 1984-07-11
DE3232034A1 (de) 1983-03-10
NZ201682A (en) 1985-08-16
FR2513126B1 (fr) 1986-04-18
NL8203315A (nl) 1983-03-16
NL192192C (nl) 1997-03-04
IL66611A0 (en) 1982-12-31

Similar Documents

Publication Publication Date Title
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
DZ452A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain.
BE894188A (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaine
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
FR2511868B1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine, un c-peptide humain et de la pro-insuline humaine
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
ATE8460T1 (de) Pharmazeutische praeparate und deren herstellung.
IT1168163B (it) Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
IT8121298A0 (it) Nitroimidazoli ad attivita'tricomonacida, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8420759A0 (it) Composizione ad attivita'farmaceutica perfezionata e sua utilizzazione per usi veterinari.
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
IT1165553B (it) Composizione farmaceutica con attivita' antiaterosclerotica e procedimento per la sua preparazione
IT1157306B (it) Vaccino contro le brucellosi umane e procedimento per la sua preparazione
Baribeau-Braün Corrélats neurophysiologiques d'attention focalisée et divisée chez des patients schizophrènes.
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.
MA19288A1 (fr) Preparations pharmaceutiques.
RO82340A2 (ro) Unguent utilizabil in terapia tulburarilor cardiace
IT8320454A0 (it) Composti ad attivita' anticataratta e preparazioni farmaceutiche cheli contengono.
ATE45956T1 (de) 11 beta-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate.